AbbVie · 2 days ago
Senior Scientist I, Biologics Analytical R&D, Analytical Development-Early Stage
North Chicago, IL
Full-time
Onsite
Senior Level, Lead/Staff
8+ years expAbbVie is a global biopharmaceutical company dedicated to innovative medicines and solutions. The Senior Scientist I role involves leading analytical development for biologics, focusing on method development, optimization, and validation to support clinical studies and product launches.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Effectively function as a senior research scientist, generating original technical ideas and research or development strategies
Demonstrate creative “out of the box” thinking to solve difficult problems and champion new analytical technologies to achieve project goals
Independently responsible for project activities within area of expertise while also contributing within the project team to the overall progress of the program
Deliver results in a team-oriented setting and willing to work across scientific disciplines to drive programs through critical milestones
Generate new scientific proposals and lead those efforts. Anticipate and critically evaluate scientific or regulatory advances or competitive threats and respond with appropriate new strategies
Effectively organize and present scientific plans and data
Author technical documents (e.g., methods, protocols, reports, etc.), scientific publications, presentations, and regulatory documents
Lead scientific experiments designed to screen platform analytical methods for incoming programs to the Biologics-ARD Early Stage group
Qualification
Required
PhD (0+ years), Master's Degree (8+ years), or Bachelor's Degree (10+ years) in scientific discipline (e.g., Analytical Chemistry, Biochemistry, or Biology) with previous laboratory experience
Practical experience and strong knowledge of protein HPLC (e.g., SEC, IEX, HIC), capillary electrophoresis, and other separation techniques as applied to protein analysis
Experience developing and transferring bioassays and ELISAs to QC setting in support of early phase release and stability testing
Must possess a solid understanding of protein chemistry and biochemistry, particularly as related to biologics drug development
Maintain a laboratory notebook in compliance with Good Laboratory/Manufacturing Practices
Demonstrated independent problem-solving ability in science and technical proficiency
Demonstrated ability to learn, understand, and master new experimental techniques
Ability to multitask and work within timelines
Demonstrated scientific writing skills and strong verbal communication skills
PhD in scientific discipline (e.g., Analytical Chemistry, Biochemistry, or Biology) with 4+ years of industry experience OR Master's degree in related fields with 8-10+ years of industry experience
Proficiency and direct experience in large biologics characterization and separation techniques, including various chromatography analytical methods (SEC/HIC/RPLC/IEC), intact or subunit mass analysis, peptide mapping
Knowledge in key analytical CMC areas, such as risk-based analytical development and method validation, CQAs, reference standard qualification, specifications, comparability
Familiarity with biologics CE, icIEF, biophysical assays, or binding and functional assays are plus
Working knowledge of lab automation, good written and oral communication skills, time management skills
Ability to work independently and collaboratively across functions
Leverage extensive expertise in Bioassay and ELISA to design, optimize, and execute robust analytical methods in GSP and GMP environments supporting biologics development and characterization
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
10001+ employees
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Robert Michael
Chairman of the Board and Chief Executive Officer
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
Recent News
WSJ.com: US Business
2026-02-05
legacy.thefly.com
2026-02-05
2026-02-05
Company data provided by crunchbase